|

Gemcitabine-Oxaliplatin Regimen Clinical Trials

1 actively recruiting trial

Also known as: PD-1 inhibitor, lenvatinib

Top Sponsors

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1

Indications

  • Intrahepatic Cholangiocarcinoma1
  • Cancer1

Other1 trial

GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.